Pacific Edge lands Australian deal; Pfizer & BioNTech update on Omicron; EBOS acquires a path into Asia.

Recap

English - December 09, 2021 03:44 - 9 minutes - 12.7 MB - ★★★★★ - 2 ratings
Investing Business Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Fletcher Building wants in on retirement villages; Qantas to help out with the post this Xmas; Stellantis revs up a new software strategy plan.

Next Episode: Amazon is fined over 1 billion dollars; Tourism Holdings merges with Aussie RV firm; 2021: a look back at the year on the NZX.

Pfizer (PFE) and BioNTech (BNTX) say that preliminary data shows a third dose of their COVID-19 vaccine improves protection against Omicron. EBOS (EBO) Group inks a deal to acquire medical equipment distributor LifeHealthcare Cancer. Pacific Edge (PEB) signs its first commercial deal of scale in Australia.

www.sharesies.com

For more share market news, subscribe to Lunch Money, Sharesies’ bite-sized email update: https://www.sharesies.nz/lunch-money

If you'd like to get in touch, for any reason at all, email [email protected] or record a voice message: https://anchor.fm/sharesies2/message.

Investing involves risk. You aren’t guaranteed to make money, and you might lose the money you start with. We don’t provide personalised advice or recommendations. Any information we provide is general only and current at the time. For specific advice, speak to a licensed financial advice provider